Skip to main content
Top
Published in: Nutrition & Metabolism 1/2010

Open Access 01-12-2010 | Research

The effect of whole grain wheat sourdough bread consumption on serum lipids in healthy normoglycemic/normoinsulinemic and hyperglycemic/hyperinsulinemic adults depends on presence of the APOE E3/E3 genotype: a randomized controlled trial

Authors: Amy J Tucker, Kathryn A MacKay, Lindsay E Robinson, Terry E Graham, Marica Bakovic, Alison M Duncan

Published in: Nutrition & Metabolism | Issue 1/2010

Login to get access

Abstract

Background

Epidemiological studies associate consumption of whole grain foods, including breads, with reduced cardiovascular disease (CVD) risk; however, few studies have compared wheat whole grains with wheat refined grains.

Methods

This study investigated effects of 6-week consumption of whole grain wheat sourdough bread in comparison to white bread on fasting serum lipids in normoglycemic/normoinsulinemic (NGI; n = 14) and hyperglycemic/hyperinsulinemic (HGI; n = 14) adults. The influence of single-nucleotide polymorphisms, 3 within the APOE gene (E2, E3, E4) and 2 within the hepatic lipase gene promoter (LIPC -514C>T, LIPC -250G>A) were considered.

Results

At baseline, HGI participants had significantly higher body weight, waist circumference, body fat, and fasted glucose, insulin, homeostasis model assessment of insulin resistance (HOMA-IR), glucagon, triacylglycerols (TAG) and TAG:HDL-cholesterol, compared to NGI participants; however, none of these in addition to none of the other serum lipids, differed between bread treatments, within either participant group. For participants with the APOE E3/E3 genotype, LDL-cholesterol (P = 0.02) increased in the NGI group (n = 7), and TAG (P = 0.03) and TAG:HDL-cholesterol (P = 0.04) increased in the HGI group (n = 10), following consumption of whole grain wheat sourdough compared to white bread.

Conclusions

In summary, 6-week consumption of whole grain wheat sourdough bread did not significantly modulate serum lipids in NGI or HGI adults; however, it significantly increased LDL-cholesterol, TAG and TAG:HDL-cholesterol in participants with the APOE E3/E3 genotype. These data add to limited literature comparing wheat whole grains to wheat refined grains on CVD risk and highlight the need to consider genetic variation in relation to lipoprotein lipid content and CVD risk.
Literature
1.
go back to reference Jacobs DR, Meyer KA, Kushi LH, Folsom AR: Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women's Health Study. Am J Clin Nutr. 1998, 68: 248-257. Jacobs DR, Meyer KA, Kushi LH, Folsom AR: Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women's Health Study. Am J Clin Nutr. 1998, 68: 248-257.
2.
go back to reference Liu S, Stampfer MJ, Hu FB, Giovannucci E, Rimm E, Manson JE, Hennekens CH, Willett WC: Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr. 1999, 70: 412-419. Liu S, Stampfer MJ, Hu FB, Giovannucci E, Rimm E, Manson JE, Hennekens CH, Willett WC: Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr. 1999, 70: 412-419.
3.
go back to reference Jacobs DR, Meyer HE, Solvoll K: Reduced mortality among whole grain bread eaters in men and women in the Norwegian County Study. Eur J Clin Nutr. 2001, 55: 137-143. 10.1038/sj.ejcn.1601133.CrossRef Jacobs DR, Meyer HE, Solvoll K: Reduced mortality among whole grain bread eaters in men and women in the Norwegian County Study. Eur J Clin Nutr. 2001, 55: 137-143. 10.1038/sj.ejcn.1601133.CrossRef
4.
go back to reference Mozaffarian D, Kumanyika SK, Lemaitre RN, Olson JL, Burke GL, Siscovick DS: Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA. 2003, 289: 1659-1666. 10.1001/jama.289.13.1659.CrossRef Mozaffarian D, Kumanyika SK, Lemaitre RN, Olson JL, Burke GL, Siscovick DS: Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA. 2003, 289: 1659-1666. 10.1001/jama.289.13.1659.CrossRef
5.
go back to reference McKeown NM, Meigs JB, Liu S, Wilson PWF, Jacques PF: Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr. 2002, 76: 390-398. McKeown NM, Meigs JB, Liu S, Wilson PWF, Jacques PF: Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr. 2002, 76: 390-398.
6.
go back to reference Jensen MK, Koh-Banerjee P, Hu FB, Franz M, Sampson L, Gronbaek M, Rimm EB: Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men. Am J Clin Nutr. 2004, 80: 1492-1499. Jensen MK, Koh-Banerjee P, Hu FB, Franz M, Sampson L, Gronbaek M, Rimm EB: Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men. Am J Clin Nutr. 2004, 80: 1492-1499.
7.
go back to reference Erkkila AT, Herrington DM, Mozaffarian D, Lichtenstein AH: Cereal fiber and whole-grain intake are associated with reduced progression of coronary-artery atherosclerosis in postmenopausal women with coronary artery disease. Am Heart J. 2005, 150: 94-101. 10.1016/j.ahj.2004.08.013.CrossRef Erkkila AT, Herrington DM, Mozaffarian D, Lichtenstein AH: Cereal fiber and whole-grain intake are associated with reduced progression of coronary-artery atherosclerosis in postmenopausal women with coronary artery disease. Am Heart J. 2005, 150: 94-101. 10.1016/j.ahj.2004.08.013.CrossRef
8.
go back to reference Mellen PB, Liese AD, Tooze JA, Vitolins MZ, Wagenknecht LE, Herrington DM: Whole-grain intake and carotid artery atherosclerosis in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr. 2007, 85: 1495-1502. Mellen PB, Liese AD, Tooze JA, Vitolins MZ, Wagenknecht LE, Herrington DM: Whole-grain intake and carotid artery atherosclerosis in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr. 2007, 85: 1495-1502.
9.
go back to reference Sahyoun NR, Jacques PF, Zhang XL, Juan W, McKeown NM: Whole-grain intake is inversely associated with the metabolic syndrome and mortality in older adults. Am J Clin Nutr. 2006, 83: 124-131. Sahyoun NR, Jacques PF, Zhang XL, Juan W, McKeown NM: Whole-grain intake is inversely associated with the metabolic syndrome and mortality in older adults. Am J Clin Nutr. 2006, 83: 124-131.
10.
go back to reference McKeown NM, Yoshida M, Shea MK, Jacques PF, Lichtenstein AH, Rogers G, Booth SL, Saltzman E: Whole-grain intake and cereal fiber are associated with lower abdominal adiposity in older adults. J Nutr. 2009, 139: 1950-1955. 10.3945/jn.108.103762.CrossRef McKeown NM, Yoshida M, Shea MK, Jacques PF, Lichtenstein AH, Rogers G, Booth SL, Saltzman E: Whole-grain intake and cereal fiber are associated with lower abdominal adiposity in older adults. J Nutr. 2009, 139: 1950-1955. 10.3945/jn.108.103762.CrossRef
11.
go back to reference Anderson JW: Whole grains protect against atherosclerotic cardiovascular disease. Proc Nutr Soc. 2003, 62: 135-142. 10.1079/PNS2002222.CrossRef Anderson JW: Whole grains protect against atherosclerotic cardiovascular disease. Proc Nutr Soc. 2003, 62: 135-142. 10.1079/PNS2002222.CrossRef
12.
go back to reference Anderson JW, Hanna TJ, Peng X, Kryscio RJ: Whole grain foods and heart disease risk. J Am Coll Nutr. 2000, 19: 291S-299S.CrossRef Anderson JW, Hanna TJ, Peng X, Kryscio RJ: Whole grain foods and heart disease risk. J Am Coll Nutr. 2000, 19: 291S-299S.CrossRef
13.
go back to reference Slavin J: Why whole grains are protective: biological mechanisms. Proc Nutr Soc. 2003, 62: 129-134. 10.1079/PNS2002221.CrossRef Slavin J: Why whole grains are protective: biological mechanisms. Proc Nutr Soc. 2003, 62: 129-134. 10.1079/PNS2002221.CrossRef
14.
go back to reference Mann J: Dietary carbohydrate: relationship to cardiovascular disease and disorders of carbohydrate metabolism. Eur J Clin Nutr. 2007, 61 (Suppl 1): S100-111. 10.1038/sj.ejcn.1602940.CrossRef Mann J: Dietary carbohydrate: relationship to cardiovascular disease and disorders of carbohydrate metabolism. Eur J Clin Nutr. 2007, 61 (Suppl 1): S100-111. 10.1038/sj.ejcn.1602940.CrossRef
15.
go back to reference Slavin JL, Jacobs D, Marquart L, Wiemer K: The role of whole grains in disease prevention. J Am Diet Assoc. 2001, 101: 780-785. 10.1016/S0002-8223(01)00194-8.CrossRef Slavin JL, Jacobs D, Marquart L, Wiemer K: The role of whole grains in disease prevention. J Am Diet Assoc. 2001, 101: 780-785. 10.1016/S0002-8223(01)00194-8.CrossRef
16.
go back to reference Bjorck I, Elmstahl HL: The glycaemic index: importance of dietary fibre and other food properties. Proc Nutr Soc. 2003, 62: 201-206. 10.1079/PNS2002239.CrossRef Bjorck I, Elmstahl HL: The glycaemic index: importance of dietary fibre and other food properties. Proc Nutr Soc. 2003, 62: 201-206. 10.1079/PNS2002239.CrossRef
17.
go back to reference Poutanen K, Flander L, Katina K: Sourdough and cereal fermentation in a nutritional perspective. Food Microbiol. 2009, 26: 693-699. 10.1016/j.fm.2009.07.011.CrossRef Poutanen K, Flander L, Katina K: Sourdough and cereal fermentation in a nutritional perspective. Food Microbiol. 2009, 26: 693-699. 10.1016/j.fm.2009.07.011.CrossRef
18.
go back to reference Lappi J, Selinheimo E, Schwab U, Katina K, Lehtinen T, Mykkanen H, Kolehmainen M, Poutanen K: Sourdough fermentation of wholemeal bread increases solubility of arabinoxylan and protein and decreases postprandial glucose and insulin responses. J Cereal Sci. 2010, 51: 152-158. 10.1016/j.jcs.2009.11.006.CrossRef Lappi J, Selinheimo E, Schwab U, Katina K, Lehtinen T, Mykkanen H, Kolehmainen M, Poutanen K: Sourdough fermentation of wholemeal bread increases solubility of arabinoxylan and protein and decreases postprandial glucose and insulin responses. J Cereal Sci. 2010, 51: 152-158. 10.1016/j.jcs.2009.11.006.CrossRef
19.
go back to reference Najjar AM, Parsons PM, Duncan AM, Robinson LE, Yada RY, Graham TE: The acute impact of ingestion of breads of varying composition on blood glucose, insulin and incretins following first and second meals. Br J Nutr. 2008, 1-8. Najjar AM, Parsons PM, Duncan AM, Robinson LE, Yada RY, Graham TE: The acute impact of ingestion of breads of varying composition on blood glucose, insulin and incretins following first and second meals. Br J Nutr. 2008, 1-8.
20.
go back to reference Maioli M, Pes GM, Sanna M, Cherchi S, Dettori M, Manca E, Farris GA: Sourdough-leavened bread improves postprandial glucose and insulin plasma levels in subjects with impaired glucose tolerance. Acta Diabetol. 2008, 45: 91-96. 10.1007/s00592-008-0029-8.CrossRef Maioli M, Pes GM, Sanna M, Cherchi S, Dettori M, Manca E, Farris GA: Sourdough-leavened bread improves postprandial glucose and insulin plasma levels in subjects with impaired glucose tolerance. Acta Diabetol. 2008, 45: 91-96. 10.1007/s00592-008-0029-8.CrossRef
21.
go back to reference Grundy SM, Abate N, Chandalia M: Diet composition and the metabolic syndrome: what is the optimal fat intake?. Am J Med. 2002, 113 (Suppl 9B): 25S-29S. 10.1016/S0002-9343(01)00988-3.CrossRef Grundy SM, Abate N, Chandalia M: Diet composition and the metabolic syndrome: what is the optimal fat intake?. Am J Med. 2002, 113 (Suppl 9B): 25S-29S. 10.1016/S0002-9343(01)00988-3.CrossRef
22.
go back to reference Andersson A, Tengblad S, Karlstrom B, Kamal-Eldin A, Landberg R, Basu S, Aman P, Vessby B: Whole-grain foods do not affect insulin sensitivity or markers of lipid peroxidation and inflammation in healthy, moderately overweight subjects. J Nutr. 2007, 137: 1401-1407. Andersson A, Tengblad S, Karlstrom B, Kamal-Eldin A, Landberg R, Basu S, Aman P, Vessby B: Whole-grain foods do not affect insulin sensitivity or markers of lipid peroxidation and inflammation in healthy, moderately overweight subjects. J Nutr. 2007, 137: 1401-1407.
23.
go back to reference Pereira MA, Jacobs DR, Pins JJ, Raatz SK, Gross MD, Slavin JL, Seaquist ER: Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr. 2002, 75: 848-855. Pereira MA, Jacobs DR, Pins JJ, Raatz SK, Gross MD, Slavin JL, Seaquist ER: Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr. 2002, 75: 848-855.
24.
go back to reference Katcher HI, Legro RS, Kunselman AR, Gillies PJ, Demers LM, Bagshaw DM, Kris-Etherton PM: The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am J Clin Nutr. 2008, 87: 79-90. Katcher HI, Legro RS, Kunselman AR, Gillies PJ, Demers LM, Bagshaw DM, Kris-Etherton PM: The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am J Clin Nutr. 2008, 87: 79-90.
25.
go back to reference McIntosh GH, Noakes M, Royle PJ, Foster PR: Whole-grain rye and wheat foods and markers of bowel health in overweight middle-aged men. Am J Clin Nutr. 2003, 77: 967-974. McIntosh GH, Noakes M, Royle PJ, Foster PR: Whole-grain rye and wheat foods and markers of bowel health in overweight middle-aged men. Am J Clin Nutr. 2003, 77: 967-974.
26.
go back to reference Giacco R, Clemente G, Cipriano D, Luongo D, Viscovo D, Patti L, DiMarino L, Giacco A, Naviglio D, Bianchi MA, Ciati R, Brighenti F, Rivellese AA, Riccardi G: Effects of the regular consumption of wholemeal wheat foods on cardiovascular risk factors in healthy people. Nutr Metab Cardiovasc Dis. 2009, doi:10.1016/j.numecd.2009.03.025 Giacco R, Clemente G, Cipriano D, Luongo D, Viscovo D, Patti L, DiMarino L, Giacco A, Naviglio D, Bianchi MA, Ciati R, Brighenti F, Rivellese AA, Riccardi G: Effects of the regular consumption of wholemeal wheat foods on cardiovascular risk factors in healthy people. Nutr Metab Cardiovasc Dis. 2009, doi:10.1016/j.numecd.2009.03.025
27.
go back to reference Sabovic M, Lavre S, Keber I: Supplementation of wheat fibre can improve risk profile in patients with dysmetabolic cardiovascular syndrome. Eur J Cardiovasc Prev Rehabil. 2004, 11: 144-148. 10.1097/01.hjr.0000124213.21584.75.CrossRef Sabovic M, Lavre S, Keber I: Supplementation of wheat fibre can improve risk profile in patients with dysmetabolic cardiovascular syndrome. Eur J Cardiovasc Prev Rehabil. 2004, 11: 144-148. 10.1097/01.hjr.0000124213.21584.75.CrossRef
28.
go back to reference Vuksan V, Jenkins DJ, Vidgen E, Ransom TP, Ng MK, Culhane CT, O'Connor D: A novel source of wheat fiber and protein: effects on fecal bulk and serum lipids. Am J Clin Nutr. 1999, 69: 226-230. Vuksan V, Jenkins DJ, Vidgen E, Ransom TP, Ng MK, Culhane CT, O'Connor D: A novel source of wheat fiber and protein: effects on fecal bulk and serum lipids. Am J Clin Nutr. 1999, 69: 226-230.
29.
go back to reference Costabile A, Klinder A, Fava F, Napolitano A, Fogliano V, Leonard C, Gibson GR, Tuohy KM: Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Br J Nutr. 2008, 99: 110-120. 10.1017/S0007114507793923.CrossRef Costabile A, Klinder A, Fava F, Napolitano A, Fogliano V, Leonard C, Gibson GR, Tuohy KM: Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Br J Nutr. 2008, 99: 110-120. 10.1017/S0007114507793923.CrossRef
30.
go back to reference Lairon D, Play B, Jourdheuil-Rahmani D: Digestible and indigestible carbohydrates: interactions with postprandial lipid metabolism. J Nutr Biochem. 2007, 18: 217-227. 10.1016/j.jnutbio.2006.08.001.CrossRef Lairon D, Play B, Jourdheuil-Rahmani D: Digestible and indigestible carbohydrates: interactions with postprandial lipid metabolism. J Nutr Biochem. 2007, 18: 217-227. 10.1016/j.jnutbio.2006.08.001.CrossRef
31.
go back to reference Hlebowicz J, Lindstedt S, Bjorgell O, Hoglund P, Almer LO, Darwiche G: The botanical integrity of wheat products influences the gastric distention and satiety in healthy subjects. Nutr J. 2008, 7: 12-10.1186/1475-2891-7-12.CrossRef Hlebowicz J, Lindstedt S, Bjorgell O, Hoglund P, Almer LO, Darwiche G: The botanical integrity of wheat products influences the gastric distention and satiety in healthy subjects. Nutr J. 2008, 7: 12-10.1186/1475-2891-7-12.CrossRef
32.
go back to reference Jenkins DJ, Kendall CW, Vuksan V, Augustin LS, Mehling C, Parker T, Vidgen E, Lee B, Faulkner D, Seyler H, Josse R, Leiter LA, Connelly PW, Fulgoni V: Effect of wheat bran on serum lipids: influence of particle size and wheat protein. J Am Coll Nutr. 1999, 18: 159-165.CrossRef Jenkins DJ, Kendall CW, Vuksan V, Augustin LS, Mehling C, Parker T, Vidgen E, Lee B, Faulkner D, Seyler H, Josse R, Leiter LA, Connelly PW, Fulgoni V: Effect of wheat bran on serum lipids: influence of particle size and wheat protein. J Am Coll Nutr. 1999, 18: 159-165.CrossRef
33.
go back to reference Jenkins DJ, Kendall CW, Augustin LS, Martini MC, Axelsen M, Faulkner D, Vidgen E, Parker T, Lau H, Connelly PW, Teitel J, Singer W, Vandenbroucke AC, Leiter LA, Josse RG: Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes. Diabetes Care. 2002, 25: 1522-1528. 10.2337/diacare.25.9.1522.CrossRef Jenkins DJ, Kendall CW, Augustin LS, Martini MC, Axelsen M, Faulkner D, Vidgen E, Parker T, Lau H, Connelly PW, Teitel J, Singer W, Vandenbroucke AC, Leiter LA, Josse RG: Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes. Diabetes Care. 2002, 25: 1522-1528. 10.2337/diacare.25.9.1522.CrossRef
34.
go back to reference Lovegrove JA, Gitau R: Nutrigenetics and CVD: what does the future hold?. Proc Nutr Soc. 2008, 67: 206-213. 10.1017/S0029665108007040.CrossRef Lovegrove JA, Gitau R: Nutrigenetics and CVD: what does the future hold?. Proc Nutr Soc. 2008, 67: 206-213. 10.1017/S0029665108007040.CrossRef
35.
go back to reference Ordovas JM: Nutrigenetics, plasma lipids, and cardiovascular risk. J Am Diet Assoc. 2006, 106: 1074-1081. 10.1016/j.jada.2006.04.016. quiz 1083CrossRef Ordovas JM: Nutrigenetics, plasma lipids, and cardiovascular risk. J Am Diet Assoc. 2006, 106: 1074-1081. 10.1016/j.jada.2006.04.016. quiz 1083CrossRef
36.
go back to reference Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC: Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002, 155: 487-495. 10.1093/aje/155.6.487.CrossRef Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC: Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002, 155: 487-495. 10.1093/aje/155.6.487.CrossRef
37.
go back to reference Couture P, Otvos JD, Cupples LA, Lahoz C, Wilson PW, Schaefer EJ, Ordovas JM: Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 2000, 20: 815-822.CrossRef Couture P, Otvos JD, Cupples LA, Lahoz C, Wilson PW, Schaefer EJ, Ordovas JM: Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 2000, 20: 815-822.CrossRef
38.
go back to reference Canada's Food Guide from Health Canada. Last updated 2007-02-05 Canada's Food Guide from Health Canada. Last updated 2007-02-05
39.
go back to reference Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.
40.
go back to reference Fink PC, Romer M, Haeckel R, Fateh-Moghadam A, Delanghe J, Gressner AM, Dubs RW: Measurement of proteins with the Behring Nephelometer. A multicentre evaluation. J Clin Chem Clin Biochem. 1989, 27: 261-276. Fink PC, Romer M, Haeckel R, Fateh-Moghadam A, Delanghe J, Gressner AM, Dubs RW: Measurement of proteins with the Behring Nephelometer. A multicentre evaluation. J Clin Chem Clin Biochem. 1989, 27: 261-276.
41.
go back to reference Wood KCM, Fullerton MD, El-Sohemy A, Bakovic M: Interactions between hepatic lipase and apolipoprotein E polymorphisms affect serum lipid profiles of healthy Canadian adults. Appl Physiol Nutr Metab. 2008, 33: 761-768. 10.1139/H08-054.CrossRef Wood KCM, Fullerton MD, El-Sohemy A, Bakovic M: Interactions between hepatic lipase and apolipoprotein E polymorphisms affect serum lipid profiles of healthy Canadian adults. Appl Physiol Nutr Metab. 2008, 33: 761-768. 10.1139/H08-054.CrossRef
42.
go back to reference van't Hooft FM, Lundahl B, Ragogna F, Karpe F, Olivecrona G, Hamsten A: Functional characterization of 4 polymorphisms in promoter region of hepatic lipase gene. Arterioscler Thromb Vasc Biol. 2000, 20: 1335-1339.CrossRef van't Hooft FM, Lundahl B, Ragogna F, Karpe F, Olivecrona G, Hamsten A: Functional characterization of 4 polymorphisms in promoter region of hepatic lipase gene. Arterioscler Thromb Vasc Biol. 2000, 20: 1335-1339.CrossRef
43.
go back to reference Dolega-Cieszkowski JH, Bobyn JP, Whiting SJ: Dietary intakes of Canadians in the 1990s using population-weighted data derived from the provincial nutrition surveys. Appl Physiol Nutr Metab. 2006, 31: 753-758. 10.1139/H06-096.CrossRef Dolega-Cieszkowski JH, Bobyn JP, Whiting SJ: Dietary intakes of Canadians in the 1990s using population-weighted data derived from the provincial nutrition surveys. Appl Physiol Nutr Metab. 2006, 31: 753-758. 10.1139/H06-096.CrossRef
44.
go back to reference Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988, 8: 1-21.CrossRef Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988, 8: 1-21.CrossRef
45.
go back to reference Ordovas JM: The genetics of serum lipid responsiveness to dietary interventions. Proc Nutr Soc. 1999, 58: 171-187. 10.1079/PNS19990023.CrossRef Ordovas JM: The genetics of serum lipid responsiveness to dietary interventions. Proc Nutr Soc. 1999, 58: 171-187. 10.1079/PNS19990023.CrossRef
46.
go back to reference Cobb MM, Teitlebaum H, Risch N, Jekel J, Ostfeld A: Influence of dietary fat apolipoprotein E phenotype, and sex on plasma lipoprotein levels. Circulation. 1992, 86: 849-857.CrossRef Cobb MM, Teitlebaum H, Risch N, Jekel J, Ostfeld A: Influence of dietary fat apolipoprotein E phenotype, and sex on plasma lipoprotein levels. Circulation. 1992, 86: 849-857.CrossRef
47.
go back to reference Clifton PM, Abbey M, Noakes M, Beltrame S, Rumbelow N, Nestel PJ: Body fat distribution is a determinant of the high-density lipoprotein response to dietary fat and cholesterol in women. Arterioscler Thromb Vasc Biol. 1995, 15: 1070-1078.CrossRef Clifton PM, Abbey M, Noakes M, Beltrame S, Rumbelow N, Nestel PJ: Body fat distribution is a determinant of the high-density lipoprotein response to dietary fat and cholesterol in women. Arterioscler Thromb Vasc Biol. 1995, 15: 1070-1078.CrossRef
48.
go back to reference Lopez-Miranda J, Ordovas JM, Mata P, Lichtenstein AH, Clevidence B, Judd JT, Schaefer EJ: Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res. 1994, 35: 1965-1975. Lopez-Miranda J, Ordovas JM, Mata P, Lichtenstein AH, Clevidence B, Judd JT, Schaefer EJ: Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res. 1994, 35: 1965-1975.
49.
go back to reference Miettinen TA, Gylling H, Vanhanen H: Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet. 1988, 2: 1261-10.1016/S0140-6736(88)90862-8.CrossRef Miettinen TA, Gylling H, Vanhanen H: Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet. 1988, 2: 1261-10.1016/S0140-6736(88)90862-8.CrossRef
50.
go back to reference Uusitupa MI, Ruuskanen E, Makinen E, Laitinen J, Toskala E, Kervinen K, Kesaniemi YA: A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J Am Coll Nutr. 1992, 11: 651-659.CrossRef Uusitupa MI, Ruuskanen E, Makinen E, Laitinen J, Toskala E, Kervinen K, Kesaniemi YA: A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J Am Coll Nutr. 1992, 11: 651-659.CrossRef
51.
go back to reference Jenkins DJ, Hegele RA, Jenkins AL, Connelly PW, Hallak K, Bracci P, Kashtan H, Corey P, Pintilia M, Stern H: The apolipoprotein E gene and the serum low-density lipoprotein cholesterol response to dietary fiber. Metabolism. 1993, 42: 585-593. 10.1016/0026-0495(93)90217-C.CrossRef Jenkins DJ, Hegele RA, Jenkins AL, Connelly PW, Hallak K, Bracci P, Kashtan H, Corey P, Pintilia M, Stern H: The apolipoprotein E gene and the serum low-density lipoprotein cholesterol response to dietary fiber. Metabolism. 1993, 42: 585-593. 10.1016/0026-0495(93)90217-C.CrossRef
52.
go back to reference Iizuka K, Horikawa Y: ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocr J. 2008, 55: 617-624. 10.1507/endocrj.K07E-110.CrossRef Iizuka K, Horikawa Y: ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocr J. 2008, 55: 617-624. 10.1507/endocrj.K07E-110.CrossRef
Metadata
Title
The effect of whole grain wheat sourdough bread consumption on serum lipids in healthy normoglycemic/normoinsulinemic and hyperglycemic/hyperinsulinemic adults depends on presence of the APOE E3/E3 genotype: a randomized controlled trial
Authors
Amy J Tucker
Kathryn A MacKay
Lindsay E Robinson
Terry E Graham
Marica Bakovic
Alison M Duncan
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2010
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/1743-7075-7-37

Other articles of this Issue 1/2010

Nutrition & Metabolism 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.